E-DRUG Archives (by date)

• Thread Index

March 31, 2005
• [e-drug] Malaria not rolling back...
  • From: "Daniel Berman" <Daniel.BERMAN@paris.msf.org>
March 30, 2005
• [e-drug] Cost effectiveness and cost benefit analysis (1)
  • From: "Kirsten Myhr" <myhr@online.no>
March 29, 2005
• [e-drug] FDA efforts to undermine Declaration of Helsinki
  • From: "Peter Lurie" <PLURIE@citizen.org>
• [e-drug] Conference: Risks of counterfeits in importation
  • From: "Bryan Liang" <baliang@alum.mit.edu>
• [e-drug] Cost effectiveness and cost benefit analysis
  • From: "Abanum Mark" <mark_opollo@yahoo.com>
March 28, 2005
• [e-drug] TB: An Old Disease Needs New Cures
  • From: "Rachel Cohen" <rachel.cohen@newyork.msf.org>
March 27, 2005
• [e-drug] Khat use as risk factor for psychotic disorders
  • From: "E-drug" <e-drug@healthnet.org>
March 26, 2005
• [e-drug] Methylene Blue alternatives? (3)
  • From: "RANA ZABAD" <r_zabad@msn.com>
March 25, 2005
• [e-drug] Methylene Blue alternatives? (2)
  • From: "offerhausl" <offerhausl@euronet.nl>
• [e-drug] Vitamins, minerals as prescription drugs?
  • From: "Joel Lexchin" <joel.lexchin@utoronto.ca>
• [e-drug] Drugs removed from the Canadian market (2)
  • From: "Charles Medawar" <charles@socialaudit.org.uk>
March 24, 2005
• [e-drug] IDA Solutions positions available
  • From: "Heather Houlihan" <hhoulihan@ida.nl>
• [e-drug] MSF statement about the new Indian Patent Bill
  • From: "E-Drug" <e-drug@healthnet.org>
March 23, 2005
• [e-drug] AIDS-Care-Watch Campaign Launch Announcement
  • From: "Mathurot Chuladul" <mathurot@hdnet.org>
• [e-drug] MSF: Simple & Rapid Diagnostic Tools Key for Fighting TB
  • From: "Rachel COHEN" <rachel.cohen@newyork.msf.org>
• [e-drug] New international ARV monographs
  • From: "Sabine Kopp" <kopps@who.int>
• [e-drug] WHO Model List of Essential Medicines and Patents
  • From: "Hans Hogerzeil" <hogerzeilh@who.int>
March 22, 2005
• [e-drug] Drugs removed from the Canadian market
  • From: "Joel Lexchin (York)" <jlexchin@yorku.ca>
• [e-drug] Joint statement Indian NGOs and MSF on passage of Indian patent law
  • From: "Rachel COHEN" <rachel.cohen@newyork.msf.org>
• [e-drug] The Economist: An overdose of bad news
  • From: "Libby Levison" <libby@theplateau.com>
• [e-drug] Codex and vitamins
  • From: "Joel Lexchin" <joel.lexchin@utoronto.ca>
March 21, 2005
• [e-drug] India designated 16th PEPFAR country
  • From: "Rachel COHEN" <rachel.cohen@newyork.msf.org>
• [e-drug] AP-groups critical of India on patent laws
  • From: "Rachel COHEN" <rachel.cohen@newyork.msf.org>
• [e-drug] TB Alliance and GSK to Develop New TB Therapies
  • From: "Sarah Ee" <sarah.ee@tballiance.org>
March 18, 2005
• [e-drug] FT: India's opposition rejects law
  • From: "Nathan Ford" <nathan.ford@london.msf.org>
March 17, 2005
• [e-drug] Course on Tropical Medicine
  • From: "Fondazione de Carneri" <info@fondazionedecarneri.it>
• [e-drug] E-Learning Course: Management of Medicines in International Health
  • From: "Tanja Schwering" <tanja.schwering@inwent.org>
March 16, 2005
• [e-drug] Motion for India from the 3rd Francophone Days on HIV/AIDS
  • From: "Ellen T HOEN" <Ellen.T.HOEN@paris.msf.org>
• [e-drug] RFI: Good references on Drug Supply Management (4)
  • From: "Carolyn Green" <cgreen@aidsalliance.org>
March 15, 2005
• [e-drug] Letter from UN Envoy HIV AIDS to Indian PM and President
  • From: "Ellen T HOEN" <Ellen.T.HOEN@paris.msf.org>
• [e-drug] free text medline searching
  • From: "E-Drug" <e-drug@healthnet.org>
March 14, 2005
• [e-drug] Demand for 2 originator ARVs could soon exceed supply (3)
  • From: "Brook Baker" <B.Baker@neu.edu>
• [e-drug] Medicine prices in Lebanon
  • From: "Margaret Ewen" <marg@haiweb.org>
• [e-drug] Methylene Blue alternatives?
  • From: "zahid ghous" <zahidghous@yahoo.com.au>
• [e-drug] Demand for 2 originator ARVs could soon exceed supply (3)
  • From: "Fernando Pascual Martmnez" <Fernando.PASCUAL@geneva.msf.org>
• [e-drug] RFI: Pharmaco-vigilance (4)
  • From: "Shanthi Pal" <pals@who.int>
• [e-drug] RFI: Pharmaco-vigilance (3)
  • From: "Joseph Serutoke" <Serutokej@ug.afro.who.int>
March 13, 2005
• [e-drug] RFI: Pharmaco-vigilance (2)
  • From: "Andrea Tarr" <andreatarr@btconnect.com>
• [e-drug] RFI: Pharmaco-vigilance
  • From: "Olutayo Adetokunbo" <oamoronkeji@yahoo.com>
March 12, 2005
• [e-drug] Medicaid Rarely Ensures Accuracy of Prescription Drug Prices
  • From: "Joana Ramos" <joaninha@comcast.net>
• [e-drug] IFPMA reaction to R&D Treaty proposal
  • From: "James Love" <james.love@cptech.org>
• [e-drug] Dose of artesunate and amodiaquine (2)
  • From: "FHJansen" <Fhjansen@skynet.be>
March 11, 2005
• [e-drug] RFI: Good references on Drug Supply Management (3)
  • From: "Holland,Ross" <rholland@msh.org>
• [e-drug] RFI: Good references on Drug Supply Management (2)
  • From: "Kibumba George" <kibumba@yahoo.com>
• [e-drug] Foreign nations lobbying for patents law
  • From: "Ellen T HOEN" <Ellen.T.HOEN@paris.msf.org>
• [e-drug] RFI: Good references on Drug Supply Management
  • From: "Jooste, Miss Jacqui" <Jacqui.Jooste@nmmu.ac.za>
• [e-drug] Use of Maloprim as malaria chemoprophylaxis (4)
  • From: "Ethelda Chikumbo" <westend@africaonline.co.zw>
March 10, 2005
• [e-drug] Use of Paracheck malaria diagnostic (2)
  • From: "Dr Stephen Vrede" <vredpeet@cq-link.sr>
• [e-drug] Adherence of Private Practitioners with TB Guidelines in Pakistan
  • From: "Azhar Hussain" <azhar_hussain@hamdard-isb.edu.pk>
• [e-drug] Dose of artesunate+ amodiaquine
  • From: "godspower okangba" <gokangba98@yahoo.com>
• [e-drug] joint drug basket experiences in Africa?
  • From: "Wilbert Bannenberg" <wjb@wxs.nl>
• [e-drug] Growing Artemisia annua in tropical Africa (6)
  • From: "plantwild" <plantwild@wanadoo.fr>
March 09, 2005
• [e-drug] Demand for 2 originator ARVs could soon exceed supply
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] Glaxo GMP problems in USA; FDA bans distribution
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] Concurrent use of Co-trimoxazole and ACT in children (2)
  • From: "FHJansen" <Fhjansen@skynet.be>
March 08, 2005
• [e-drug] 2005 SEAM Conference -- Targeting Improved Access
  • From: "Johnson,Keith" <kjohnson@msh.org>
• [e-drug] Use of Paracheck malaria diagnotic
  • From: "Barbara Neitzert" <barbara.neitzert@online.fr>
• RE: [e-drug] Myths about hospital formularies persist (7)
  • From: "Bernard Van de Wal" <bwvdewal@sun.ac.za>
March 07, 2005
• [e-drug] BMJ on abstinence and AIDS in Uganda
  • From: "Valeria Frighi" <valeria.frighi@doctors.org.uk>
• [e-drug] Concurrent use of Co-trimoxazole and ACT in children
  • From: "adenrele koleade" <koleadea@yahoo.com>
• [e-drug] HealthNet News Special Edition on Neonatal Survival
  • From: "Leela McCullough" <leela@healthnet.org>
• [e-drug] Myths about hospital formularies persist (6)
  • From: "Dr.L.Offerhaus" <offerhausl@euronet.nl>
March 06, 2005
• [e-drug] Myths about hospital formularies persist (5)
  • From: "Francis Juma" <fdjuma@yahoo.com>
• [e-drug] Biosimilar Compounds
  • From: "Dr. Majid Cheraghali" <m.cheraghali@bmsu.ac.ir>
March 05, 2005
• [e-drug] The Lancet - Neonatal Survival Series
  • From: "Valeria Frighi" <valeria.frighi@doctors.org.uk>
March 04, 2005
• [e-drug] Use of Maloprim as malaria chemoprophylaxis (3)
  • From: "Douglas Ball" <douglasball@yahoo.co.uk>
• [e-drug] Vacancy: National Project Manager DFID Nigeria
  • From: "Suzanne Law" <suzanne.law@hlsp.org>
• [e-drug] Book: IP in the context of the WTO TRIPS agreement
  • From: "Gabriela" <gabi@ensp.fiocruz.br>
• [e-drug] Managing Drug Supply course 2005
  • From: "Andrew Marshall" <amarshall@ida.nl>
• [e-drug] Use of Maloprim as malaria chemoprophylaxis (2)
  • From: "Andy Gray" <Graya1@ukzn.ac.za>
March 03, 2005
• [e-drug] GlaxoSmithKline aims to stop ARV reimportation (2)
  • From: "Akunne Anayo" <akunneaf@netscape.net>
• [e-drug] Use of Maloprim as malaria chemoprophylaxis (1)
  • From: "Dr S Toovey" <toovey@travelclinic.co.za>
• [e-drug] FIP launches webpage on Counterfeit Medicines
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] Use of Maloprim as malaria chemoprophylaxis
  • From: "Kae Ting Trouilloud" <kaecherie@yahoo.co.uk>
March 02, 2005
• [e-drug] Repackaging medicines in pharmacies (6)
  • From: "Donald Light" <dlight@Princeton.EDU>
• [e-drug] GSK aims to stop ARV reimportation (3)
  • From: "Kevin Outterson" <Kevin.Outterson@mail.wvu.edu>
• [e-drug] Global tobacco treaty enters into force
  • From: "Leela McCullough" <leela@healthnet.org>
• [e-drug] Short Courses in International Health at Heidelberg University
  • From: "Natascha Petersen" <natascha_petersen@urz.uni-heidelberg.de>
• [e-drug] GlaxoSmithKline aims to stop ARV reimportation (2)
  • From: "Murtada Sesay" <msesay@unicef.org>
March 01, 2005
• [e-drug] Updated International Drug Price Indicator Guide
  • From: "Julie McFadyen" <jmcfadyen@msh.org>
• [e-drug] GlaxoSmithKline aims to stop ARV reimportation (1)
  • From: "Kevin Outterson" <Kevin.Outterson@mail.wvu.edu>
• [e-drug] a new essential health R&D treaty
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] GlaxoSmithKline aims to stop ARV reimportation
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] Training course in Supply Chain Management of HIV/AIDS Medicines&Supplies
  • From: "Clarisse Audrey Morris" <camorris@ida.nl>
• [e-drug] Inappropriate donations to South East Asia (5)
  • From: "Ghislaine Soulier" <g.soulier@psf-ci.org>
• [e-drug] PLoS Medicine on Essential Health R&D Treaty
  • From: "Nicoletta Dentico" <nicolettadentico@libero.it>
February 28, 2005
• [e-drug] Repackaging medicines in pharmacies (5)
  • From: "Stein Lyftingsmo" <stein@lyftingsmo.no>
• [e-drug] Repackaging medicines in pharmacies (4)
  • From: "Sarah Sellers" <ssellers@jhsph.edu>